RGD Reference Report - Involvement of apolipoprotein E in excess fat accumulation and insulin resistance. - Rat Genome Database

Send us a Message



Submit Data |  Help |  Video Tutorials |  News |  Publications |  Download |  REST API |  Citing RGD |  Contact   

Involvement of apolipoprotein E in excess fat accumulation and insulin resistance.

Authors: Gao, J  Katagiri, H  Ishigaki, Y  Yamada, T  Ogihara, T  Imai, J  Uno, K  Hasegawa, Y  Kanzaki, M  Yamamoto, TT  Ishibashi, S  Oka, Y 
Citation: Gao J, etal., Diabetes. 2007 Jan;56(1):24-33.
RGD ID: 1601230
Pubmed: PMID:17192461   (View Abstract at PubMed)
DOI: DOI:10.2337/db06-0144   (Journal Full-text)

Although apolipoprotein E (apoE) is well known to play a major role in lipid metabolism, its role in glucose and energy homeostasis remains unclear. Herein, we established apoE-deficient genetically obese Ay (apoE(-/-);Ay/+) mice. ApoE deficiency in Ay mice prevented the development of obesity, with decreased fat accumulation in the liver and adipose tissues. ApoE(-/-);Ay/+ mice exhibited better glucose tolerance than apoE(+/+);Ay/+ mice. Insulin tolerance testing and hyperinsulinemic-euglycemic clamp study revealed marked improvement of insulin sensitivity, despite increased plasma free fatty acid levels. These metabolic phenotypes were reversed by adenoviral replenishment of apoE protein, indicating circulating apoE to be involved in increased adiposity and obesity-related metabolic disorders. Uptake of apoE-lacking VLDL into the liver and adipocytes was markedly inhibited, but adipocytes in apoE(-/-);Ay/+ mice exhibited normal differentiation, suggesting that apoE-dependent VLDL transport is involved in the development of obesity, i.e., surplus fat accumulation. Interestingly, apoE(-/-);Ay/+ mice exhibited decreased food intake and increased energy expenditure. Pair-feeding experiments indicate these phenomena to both contribute to the obesity-resistant phenotypes associated with apoE deficiency. Thus, apoE is involved in maintaining energy homeostasis. ApoE-dependent excess fat accumulation is a promising therapeutic target for the metabolic syndrome.

RGD Manual Disease Annotations    Click to see Annotation Detail View
TermQualifierEvidenceWithReferenceNotesSourceOriginal Reference(s)
diabetes mellitus treatmentIDA 1601230 RGD 
diabetes mellitus treatmentISOAPOE (Homo sapiens)1601230; 1601230 RGD 
obesity  ISOApoe (Mus musculus)1601230; 1601230 RGD 
obesity  IMP 1601230 RGD 

Objects Annotated

Genes (Rattus norvegicus)
Apoe  (apolipoprotein E)

Genes (Mus musculus)
Apoe  (apolipoprotein E)

Genes (Homo sapiens)
APOE  (apolipoprotein E)


Additional Information